Elevance Health (ELV) Short Interest Ratio & Short Volume $315.84 +6.24 (+2.01%) Closing price 08/22/2025 03:59 PM EasternExtended Trading$317.38 +1.54 (+0.49%) As of 08/22/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Elevance Health Short Interest DataElevance Health (ELV) has a short interest of 2.84 million shares, representing 1.26% of the float (the number of shares available for trading by the public). This marks a 4.41% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.2, indicating that it would take 1.2 days of the average trading volume of 2.57 million shares to cover all short positions.Current Short Interest2,840,000 sharesPrevious Short Interest2,720,000 sharesChange Vs. Previous Month+4.41%Dollar Volume Sold Short$803.83 millionShort Interest Ratio1.2 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares225,180,000 sharesFloat Size224,790,000 sharesShort Percent of Float1.26%Today's Trading Volume2,961,044 sharesAverage Trading Volume2,567,187 sharesToday's Volume Vs. Average115% Short Selling Elevance Health? Sign up to receive the latest short interest report for Elevance Health and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartELV Short Interest Over TimeELV Days to Cover Over TimeELV Percentage of Float Shorted Over Time Elevance Health Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/20252,840,000 shares $803.83 million +4.4%1.3%1.2 $283.04 7/15/20252,720,000 shares $914.08 million +7.1%1.2%1.3 $336.06 6/30/20252,540,000 shares $989.13 million +1.6%1.1%1.4 $389.42 6/15/20252,500,000 shares $961.23 million +13.6%1.1%1.4 $384.49 5/31/20252,200,000 shares $844.84 million -15.7%1.0%1.2 $384.02 5/15/20252,610,000 shares $1.02 billion -2.6%1.2%1.5 $389.42 4/30/20252,680,000 shares $1.13 billion -12.4%1.2%1.7 $420.82 4/15/20253,060,000 shares $1.34 billion +11.3%1.4%1.8 $437.83 3/31/20252,750,000 shares $1.20 billion +9.1%1.2%1.6 $435.48 3/15/20252,520,000 shares $1.06 billion +1.6%1.1%1.5 $421.72 Get the Latest News and Ratings for ELV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Elevance Health and its competitors with MarketBeat's FREE daily newsletter. 2/28/20252,480,000 shares $984.78 million -23.7%1.1%1.5 $397.09 2/15/20253,250,000 shares $1.27 billion +15.7%1.4%1.9 $389.58 1/31/20252,810,000 shares $1.11 billion -3.4%1.2%1.6 $395.82 1/15/20252,910,000 shares $1.13 billion -19.8%1.3%1.5 $388.93 12/31/20243,630,000 shares $1.34 billion +5.2%1.6%1.9 $368.90 12/15/20243,450,000 shares $1.32 billion +22.3%1.5%1.8 $381.41 11/30/20242,820,000 shares $1.15 billion -9.9%1.2%1.6 $406.96 11/15/20243,130,000 shares $1.25 billion +9.8%1.4%2 $400.78 10/31/20242,850,000 shares $1.16 billion +6.7%1.2%2.1 $405.83 10/15/20242,670,000 shares $1.29 billion +10.3%1.2%2.3 $483.87 9/30/20242,420,000 shares $1.26 billion +10.0%1.1%2.3 $520.00 9/15/20242,200,000 shares $1.21 billion +23.6%1.0%2.3 $550.84 8/31/20241,780,000 shares $991.26 million +6.6%0.8%1.8 $556.89 8/15/20241,670,000 shares $904.84 million -16.5%0.7%1.6 $541.82 7/31/20242,000,000 shares $1.06 billion +13.6%0.9%1.9 $532.01 7/15/20241,760,000 shares $933.96 million -19.6%0.8%1.6 $530.66 6/30/20242,190,000 shares $1.19 billion -4.0%1.0%2.2 $541.86 6/15/20242,280,000 shares $1.22 billion +24.6%1.0%2.2 $534.81 5/31/20241,830,000 shares $985.38 million +2.2%0.8%1.8 $538.46 5/15/20241,790,000 shares $966.58 million -14.4%0.8%1.8 $539.99 4/30/20242,090,000 shares $1.10 billion +7.7%0.9%2.2 $528.58 4/15/20241,940,000 shares $970.52 million -7.2%0.8%1.9 $500.27 3/31/20242,090,000 shares $1.08 billion -10.7%0.9%2 $518.54 3/15/20242,340,000 shares $1.20 billion +36.8%1.0%2.3 $512.77 2/29/20241,710,000 shares $857.34 million -2.8%0.7%1.6 $501.37 2/15/20241,760,000 shares $895.52 million -16.6%0.8%1.6 $508.82 1/31/20242,110,000 shares $1.04 billion +9.9%0.9%1.9 $493.44 1/15/20241,920,000 shares $912.23 million +2.1%0.8%1.8 $475.12 12/31/20231,880,000 shares $886.53 million -12.6%0.8%1.7 $471.56 12/15/20232,150,000 shares $1.01 billion +39.6%0.9%1.9 $468.06Tax Drain Deadline: Protect Your Wealth Before September 15th (Ad)On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed professionals, retirees, and high-net-worth savers. But the wealthy aren’t just writing checks. They’re moving fast to protect capital and purchasing power using legal, IRS-compliant strategies. American Alternative Assets just released the Mar-A-Lago Accord, a free guide revealing how to reduce Q3 tax exposure and reposition wealth before it’s drained.Click here to download the guide and protect your assets before Sept 15th. 11/30/20231,540,000 shares $738.63 million -21.4%0.7%1.4 $479.63 11/15/20231,960,000 shares $895.17 million -4.9%0.8%1.8 $456.72 10/31/20232,060,000 shares $927.19 million +3.5%0.9%2 $450.09 10/15/20231,990,000 shares $903.68 million -11.2%0.9%1.9 $454.11 9/30/20232,240,000 shares $975.34 million +14.9%1.0%2 $435.42 9/15/20231,950,000 shares $861.74 million +40.3%0.8%1.6 $441.92 8/31/20231,390,000 shares $614.39 million -14.2%0.6%1.1 $442.01 8/15/20231,620,000 shares $757.95 million +0.6%0.7%1.2 $467.87 7/31/20231,610,000 shares $759.29 million -3.6%0.7%1.2 $471.61 7/15/20231,670,000 shares $732.68 million +3.1%0.7%1.2 $438.73 6/30/20231,620,000 shares $719.75 million -11.0%0.7%1.3 $444.29 6/15/20231,820,000 shares $822.15 million -4.7%0.8%1.5 $451.73 5/31/20231,910,000 shares $855.26 million +3.8%0.8%1.7 $447.78 5/15/20231,840,000 shares $832.69 million -7.1%0.8%1.7 $452.55 4/30/20231,980,000 shares $927.93 million +20.7%0.8%1.8 $468.65 4/15/20231,640,000 shares $794.51 million -0.6%0.7%1.4 $484.46 3/31/20231,650,000 shares $758.69 million -20.7%0.7%1.5 $459.81 3/15/20232,080,000 shares $949.48 million +50.7%0.9%1.9 $456.48 2/28/20231,380,000 shares $648.14 million -13.8%0.6%1.3 $469.67 2/15/20231,600,000 shares $779.41 million -4.8%0.7%1.5 $487.13 1/31/20231,680,000 shares $839.98 million -0.6%0.7%1.4 $499.99 1/15/20231,690,000 shares $816.27 million -9.1%0.7%1.5 $483.00 12/30/20221,860,000 shares $954.12 million -19.8%0.8%1.6 $512.97 12/15/20222,320,000 shares $1.18 billion +19.0%1.0%2.1 $508.98 11/30/20221,950,000 shares $1.04 billion +0.5%0.8%1.8 $532.92 11/15/20221,940,000 shares $929.28 million -12.6%0.8%1.8 $479.01 10/31/20222,220,000 shares $1.21 billion -5.9%0.9%2.4 $546.77 10/15/20222,360,000 shares $1.11 billion -7.8%1.0%2.7 $470.77 9/30/20222,560,000 shares $1.16 billion -4.5%1.1%3 $454.24 9/15/20222,680,000 shares $1.30 billion +28.9%1.1%3 $485.33 8/31/20222,080,000 shares $1.01 billion No Change0.9%2.2 $485.11 8/15/20222,080,000 shares $1.03 billion -4.6%0.9%2 $493.22 7/31/20222,180,000 shares $1.04 billion -5.6%0.9%2 $477.10 7/15/20222,310,000 shares $1.13 billion No Change1.0%2 $488.92 6/15/20222,270,000 shares $1.05 billion +3.2%N/A1.9 $462.88 5/31/20222,200,000 shares $1.12 billion +21.6%0.9%1.8 $509.61 5/15/20221,810,000 shares $880.47 million No Change0.8%1.5 $486.45 4/30/20221,810,000 shares $908.49 million -16.6%0.8%1.5 $501.93 4/15/20222,170,000 shares $1.12 billion -7.3%0.9%1.7 $516.72 3/31/20222,340,000 shares $1.15 billion -3.7%N/A1.9 $491.22 3/15/20222,430,000 shares $1.14 billion +7.1%1.0%2.1 $467.69 2/28/20222,270,000 shares $1.03 billion +3.2%1.0%2 $451.85 2/15/20222,200,000 shares $989.76 million +12.2%0.9%2 $449.89 1/31/20221,960,000 shares $864.34 million +4.8%0.8%1.8 $440.99 1/15/20221,870,000 shares $845.50 million -4.6%0.8%1.8 $452.14 12/31/20211,960,000 shares $908.54 million -5.3%0.8%1.8 $463.54 12/15/20212,070,000 shares $918.17 million +1.5%0.9%1.9 $443.56 11/30/20212,040,000 shares $828.71 million -2.9%0.9%1.8 $406.23 11/15/20212,100,000 shares $912.22 million -14.6%0.9%1.9 $434.39 10/29/20212,460,000 shares $1.07 billion +1.7%1.0%2.3 $435.13Tax Drain Deadline: Protect Your Wealth Before September 15th (Ad)On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed professionals, retirees, and high-net-worth savers. But the wealthy aren’t just writing checks. They’re moving fast to protect capital and purchasing power using legal, IRS-compliant strategies. American Alternative Assets just released the Mar-A-Lago Accord, a free guide revealing how to reduce Q3 tax exposure and reposition wealth before it’s drained.Click here to download the guide and protect your assets before Sept 15th. 10/15/20212,420,000 shares $951.18 million -12.6%1.0%2.3 $393.05 9/30/20212,770,000 shares $1.03 billion +13.5%1.2%2.6 $372.80 9/15/20212,440,000 shares $913.83 million -13.2%1.0%2.3 $374.52 8/31/20212,810,000 shares $1.05 billion +10.2%1.2%2.7 $375.13 8/13/20212,550,000 shares $937.10 million -1.5%1.1%2.4 $367.49 7/30/20212,590,000 shares $994.59 million -0.4%1.1%2.5 $384.01 7/15/20212,600,000 shares $1.03 billion +4.4%1.1%2.5 $396.12 6/30/20212,490,000 shares $950.68 million +6.4%1.0%2.3 $381.80 6/15/20212,340,000 shares $900.83 million -20.4%1.0%2.2 $384.97 5/28/20212,940,000 shares $1.17 billion -5.5%1.2%2.6 $398.22 5/14/20213,110,000 shares $1.23 billion -15.7%1.3%2.6 $395.45 4/30/20213,690,000 shares $1.41 billion +4.2%1.5%2.9 $383.03 4/15/20213,540,000 shares $1.28 billion -6.8%1.5%2.6 $362.62 3/31/20213,800,000 shares $1.38 billion +18.8%1.6%2.8 $364.09 3/15/20213,200,000 shares $1.09 billion +3.2%1.3%2.4 $341.72 2/26/20213,100,000 shares $930.74 million +1.3%1.3%2.4 $300.24 2/12/20213,060,000 shares $896.09 million -4.7%1.3%2.4 $292.84 1/29/20213,210,000 shares $964.64 million +11.5%1.3%2.5 $300.51 1/15/20212,880,000 shares $928.86 million -5.0%1.2%2.1 $322.52 12/31/20203,030,000 shares $951.57 million -26.3%1.2%2.3 $314.05 12/15/20204,110,000 shares $1.27 billion +47.3%1.7%3.1 $310.10 11/30/20202,790,000 shares $872.71 million -20.7%1.1%2.1 $312.80 11/15/20203,520,000 shares $1.17 billion -10.0%1.4%2.6 $332.96 10/30/20203,910,000 shares $1.07 billion +2.9%1.6%3.1 $273.26 10/15/20203,800,000 shares $1.11 billion +4.7%1.5%3.4 $292.34 9/30/20203,630,000 shares $974.98 million +6.1%1.5%3.1 $268.59 9/15/20203,420,000 shares $889.71 million -3.4%1.4%2.9 $260.15 8/31/20203,540,000 shares $996.58 million -8.1%1.4%3 $281.52 ELV Short Interest - Frequently Asked Questions What is Elevance Health's current short interest? Short interest is the volume of Elevance Health shares that have been sold short but have not yet been closed out or covered. As of July 31st, traders have sold 2,840,000 shares of ELV short. 1.26% of Elevance Health's shares are currently sold short. Learn More on Elevance Health's current short interest. What is a good short interest ratio for Elevance Health? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ELV shares currently have a short interest ratio of 1.0. Learn More on Elevance Health's short interest ratio. Which institutional investors are shorting Elevance Health? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Elevance Health: Hudson Bay Capital Management LP, Hudson Bay Capital Management LP, Group One Trading LLC, BNP Paribas Financial Markets, Balyasny Asset Management L.P., Bank of America Corp DE, Torno Capital LLC, Jane Street Group LLC, Volterra Technologies LP, Squarepoint Ops LLC, Qube Research & Technologies Ltd, Maven Securities LTD, Capula Management Ltd, Walleye Capital LLC, Walleye Trading LLC, Eisler Capital Management Ltd., JPMorgan Chase & Co., Simplex Trading LLC, VELA Investment Management LLC, Allianz Asset Management GmbH, Twin Tree Management LP, and Quaker Wealth Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Elevance Health? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.26% of Elevance Health's floating shares are currently sold short. Is Elevance Health's short interest increasing or decreasing? Elevance Health saw a increase in short interest in the month of July. As of July 31st, there was short interest totaling 2,840,000 shares, an increase of 4.4% from the previous total of 2,720,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Elevance Health's float size? Elevance Health currently has issued a total of 225,180,000 shares. Some of Elevance Health's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Elevance Health currently has a public float of 224,790,000 shares. How does Elevance Health's short interest compare to its competitors? 1.26% of Elevance Health's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Elevance Health: Centene Corporation (5.72%), Molina Healthcare, Inc (3.27%), Cigna Group (0.93%), Humana Inc. (3.90%), UnitedHealth Group Incorporated (1.68%), Danaher Corporation (1.30%), CVS Health Corporation (1.23%), Cencora, Inc. (3.53%), Labcorp Holdings Inc. (3.32%), Natera, Inc. (3.07%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Elevance Health stock? Short selling ELV is an investing strategy that aims to generate trading profit from Elevance Health as its price is falling. ELV shares are trading up $6.24 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Elevance Health? A short squeeze for Elevance Health occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ELV, which in turn drives the price of the stock up even further. How often is Elevance Health's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ELV, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies CNC Short Squeeze MOH Short Squeeze CI Short Squeeze HUM Short Squeeze UNH Short Squeeze DHR Short Squeeze CVS Short Squeeze COR Short Squeeze LH Short Squeeze NTRA Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:ELV) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersNations are at war over what’s in this boxA resource known as Element 29 is quickly becoming one of the most sought-after materials on the planet. Goldm...Behind the Markets | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elevance Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elevance Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access